» Articles » PMID: 7658055

Human Immunodeficiency Virus Type 1 Infection: Relationship of Risk Group and Age to Rate of Progression to AIDS. Transfusion Safety Study Group

Overview
Journal J Infect Dis
Date 1995 Sep 1
PMID 7658055
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Age differences among risk groups may account for rate differences in progression of human immunodeficiency virus type 1 (HIV-1) infection to AIDS. Institutions in 6 US cities used a common protocol to study infected homosexual blood donors, recipients of blood components, and factor VIII-treated hemophiliacs. Follow-up was every 6 months. Actuarial risk for AIDS 8 years after infection was 51% among blood recipients, 36% among homosexual donors, and 24% among hemophiliacs. Significant risk group differences were explained by age differences among cohorts (medians of 61, 29, and 22 years, respectively). When age was adjusted for and both CD4 cell value and zidovudine treatment were used as time-dependent covariates, homosexual donors had more rapid progression than the other groups. Omitting Kaposi's sarcoma as an AIDS-defining condition removed any significant differences among risk groups except CD4 cell count and age. Thus, major factors in AIDS progression are age-related.

Citing Articles

Impact of schistosome infection on long-term HIV/AIDS outcomes.

Colombe S, Machemba R, Mtenga B, Lutonja P, Kalluvya S, de Dood C PLoS Negl Trop Dis. 2018; 12(7):e0006613.

PMID: 29965987 PMC: 6044552. DOI: 10.1371/journal.pntd.0006613.


Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection.

Mangal T AIDS. 2017; 31(8):1073-1082.

PMID: 28301424 PMC: 5414573. DOI: 10.1097/QAD.0000000000001437.


Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome.

Huang Y, Hong X, Xu J, Luo J, Mo H, Zhao H Immunol Res. 2015; 64(3):641-52.

PMID: 26676359 DOI: 10.1007/s12026-015-8767-5.


Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapy.

Ezeamama A, Mupere E, Oloya J, Martinez L, Kakaire R, Yin X Int J Infect Dis. 2015; 35:73-9.

PMID: 25910854 PMC: 4497838. DOI: 10.1016/j.ijid.2015.04.008.


Impact of age on markers of HIV-1 disease.

Pirrone V, Libon D, Sell C, Lerner C, Nonnemacher M, Wigdahl B Future Virol. 2013; 8(1):81-101.

PMID: 23596462 PMC: 3625689. DOI: 10.2217/fvl.12.127.